triiodothyronine has been researched along with Cancer of Head in 17 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Excerpt | Relevance | Reference |
---|---|---|
"Thyroid function was measured by means of thyroid stimulating hormone (TSH), free thyroxine (FT4) and free triiodthyronine (FT3) in 43 patients who had nonthyroid head-neck carcinomas treated by radiotherapy or radiotherapy in combination with other modalities." | 3.80 | Hypothyroidism after radiotherapy of head and neck cancer. ( Bernát, L; Hrušák, D, 2014) |
"To determine the dose-response relationship of the thyroid for radiation-induced hypothyroidism in head-and-neck radiation therapy, according to 6 normal tissue complication probability models, and to find the best-fit parameters of the models." | 1.39 | Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy. ( Bakhshandeh, M; Hashemi, B; Kazemnejad, A; Mahdavi, SR; Nikoofar, A; Vasheghani, M, 2013) |
"Radiation-induced thyroiditis is regarded as primary damage to the thyroid gland." | 1.38 | Evaluation of thyroid disorders during head-and-neck radiotherapy by using functional analysis and ultrasonography. ( Bakhshandeh, M; Edraki, HR; Hashemi, B; Kazemnejad, A; Mahdavi, SR; Nikoofar, A, 2012) |
"Hypothyroidism is recognized as a common complication of treatment in patients with head and neck carcinoma (HNC) and is reported in up to 75% of patients who receive combined treatment." | 1.31 | Pretreatment prevalence of hypothyroidism in patients with head and neck carcinoma. ( Bedrin, L; Dori, S; Horowitz, Z; Kronenberg, J; Mini, S; Peleg, M; Shoshani, Y; Taicher, S; Talmi, YP; Wolf, M, 2001) |
"transplanted parathyroid adenoma secreted parathyroid hormone (PTH) in the SCID mice for more than 1 year." | 1.30 | Morphology and function of human benign tumors and normal thyroid tissues maintained in severe combined immunodeficient mice. ( Fukuda, K; Hande, PM; Hongyo, T; Kubo, T; Kurooka, M; Li, LY; Mori, K; Nakajima, H; Nomura, T; Sutoh, K; Taniguchi, E; Wang, H, 1998) |
"Triiodothyronine (T3) was directly correlated in the cancer patients with non-oxidative glucose utilization at the two physiological insulin concentrations (r = 0." | 1.29 | Reduced non-oxidative glucose utilization in cancer patients is associated with a low triiodothyronine concentration. ( Tayek, JA, 1995) |
"The mean thyroid dose for irradiated malignant lymphomas in the prospective and the retrospective group was 45 Gy and 43 Gy respectively." | 1.28 | Incidence of hypothyroidism after irradiation of the neck with special reference to lymphoma patients. A retrospective and prospective analysis. ( Becker, W; Feyerabend, T; Kapp, B; Reiners, C; Richter, E, 1990) |
"Eleven patients with head and neck cancer (ten men, one woman; mean age, 65 years) (larynx, six; oropharynx, two; tongue, one; skin, one; thyroid, one) with regional lymph node enlargements either in contiguity or firmly adherent to the vascular structures of the neck have been treated by means of external microwaves (915, 434 MHz) applicators." | 1.28 | Serum thyroid hormone changes in head and neck cancer patients treated with microwave hyperthermia on lymph node metastasis. ( Airoldi, M; Brossa, PC; D'Alberto, M; Gabriele, P; Pedani, F; Ragona, R; Tseroni, V, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (23.53) | 18.7374 |
1990's | 4 (23.53) | 18.2507 |
2000's | 3 (17.65) | 29.6817 |
2010's | 4 (23.53) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Gülses, A | 1 |
Wagner, J | 1 |
Torst, P | 1 |
Wieker, H | 1 |
Schulte, DM | 1 |
Spille, DC | 1 |
Wiltfang, J | 1 |
Spille, J | 1 |
Haas, M | 1 |
Lein, A | 1 |
Fuereder, T | 1 |
Schnoell, J | 1 |
Brkic, FF | 1 |
Campion, NJ | 1 |
Liu, DT | 1 |
Kadletz-Wanke, L | 1 |
Heiduschka, G | 1 |
Jank, BJ | 1 |
Bernát, L | 1 |
Hrušák, D | 1 |
Bölling, T | 1 |
Geisenheiser, A | 1 |
Pape, H | 1 |
Martini, C | 1 |
Rübe, C | 1 |
Timmermann, B | 1 |
Fischedick, K | 1 |
Kortmann, RD | 1 |
Gerss, J | 1 |
Koch, R | 1 |
Willich, N | 1 |
Bakhshandeh, M | 2 |
Hashemi, B | 2 |
Mahdavi, SR | 2 |
Nikoofar, A | 2 |
Edraki, HR | 1 |
Kazemnejad, A | 2 |
Vasheghani, M | 1 |
Koc, M | 1 |
Unuvar, N | 1 |
Sen, RC | 1 |
Capoglu, I | 1 |
Sen, M | 1 |
Alterio, D | 1 |
Jereczek-Fossa, BA | 1 |
Franchi, B | 1 |
D'Onofrio, A | 1 |
Piazzi, V | 1 |
Rondi, E | 1 |
Ciocca, M | 1 |
Gibelli, B | 1 |
Grosso, E | 1 |
Tradati, N | 1 |
Mariani, L | 1 |
Boboc, GI | 1 |
Orecchia, R | 1 |
Holten, I | 1 |
Tayek, JA | 1 |
Fukuda, K | 1 |
Nakajima, H | 1 |
Taniguchi, E | 1 |
Sutoh, K | 1 |
Wang, H | 1 |
Hande, PM | 1 |
Li, LY | 1 |
Kurooka, M | 1 |
Mori, K | 1 |
Hongyo, T | 1 |
Kubo, T | 1 |
Nomura, T | 1 |
Mini, S | 1 |
Dori, S | 1 |
Horowitz, Z | 1 |
Bedrin, L | 1 |
Peleg, M | 1 |
Wolf, M | 1 |
Shoshani, Y | 1 |
Taicher, S | 1 |
Kronenberg, J | 1 |
Talmi, YP | 1 |
Feyerabend, T | 1 |
Kapp, B | 1 |
Richter, E | 1 |
Becker, W | 1 |
Reiners, C | 1 |
Airoldi, M | 1 |
Gabriele, P | 1 |
Brossa, PC | 1 |
Pedani, F | 1 |
Tseroni, V | 1 |
D'Alberto, M | 1 |
Ragona, R | 1 |
Razack, MS | 1 |
Shimaoka, K | 1 |
Sako, K | 1 |
Rao, U | 1 |
Glatstein, E | 1 |
McHardy-Young, S | 1 |
Brast, N | 1 |
Eltringham, JR | 1 |
Kriss, JP | 1 |
Hales, I | 1 |
Reeve, T | 1 |
Johnson, D | 1 |
1 trial available for triiodothyronine and Cancer of Head
Article | Year |
---|---|
Suppressive therapy of thyroid nodules in patients with previous radiotherapy to the head and neck.
Topics: Adult; Aged; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neopla | 1988 |
16 other studies available for triiodothyronine and Cancer of Head
Article | Year |
---|---|
Changes in hormones of the thyroid axis after tracheostomy and their influence on regeneration in patients with head and neck cancer: A prospective study.
Topics: Aged; Head and Neck Neoplasms; Humans; Prospective Studies; Regeneration; Thyroid Gland; Thyrotropin | 2022 |
Low free triiodothyronine and immune-related hyperthyroidism are associated with overall and progression-free survival in head and neck squamous cell carcinoma treated with pembrolizumab.
Topics: Antibodies, Monoclonal, Humanized; Carcinoma; Head and Neck Neoplasms; Humans; Hyperthyroidism; Prog | 2023 |
Hypothyroidism after radiotherapy of head and neck cancer.
Topics: Aged; Carcinoma; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Follow-Up Studies; | 2014 |
Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the "Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence" (RiSK).
Topics: Adolescent; Child; Child, Preschool; Cranial Irradiation; Germany; Head and Neck Neoplasms; Hormone | 2011 |
Evaluation of thyroid disorders during head-and-neck radiotherapy by using functional analysis and ultrasonography.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged | 2012 |
Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Confidence Intervals; Dose-Response Relationship, Radiation; Female; | 2013 |
A prospective evaluation of early thyroid dysfunction on completion of neck radiotherapy.
Topics: Adult; Aged; Case-Control Studies; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neck | 2003 |
Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: a retrospective analysis of seventy-three patients.
Topics: Adult; Aged; Biomarkers; Dose-Response Relationship, Radiation; Female; Head and Neck Neoplasms; Hum | 2007 |
Acute response of the thyroid to external radiation.
Topics: Adult; Aged; Animals; Autoantibodies; Biopsy, Needle; Cell Nucleus; Cytoplasm; Female; Follow-Up Stu | 1983 |
Reduced non-oxidative glucose utilization in cancer patients is associated with a low triiodothyronine concentration.
Topics: Blood Glucose; Calorimetry, Indirect; Carcinoma, Squamous Cell; Female; Glucose; Glucose Clamp Techn | 1995 |
Morphology and function of human benign tumors and normal thyroid tissues maintained in severe combined immunodeficient mice.
Topics: Adenoma; Animals; Female; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Male; Mice; Mice, S | 1998 |
Pretreatment prevalence of hypothyroidism in patients with head and neck carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; H | 2001 |
Incidence of hypothyroidism after irradiation of the neck with special reference to lymphoma patients. A retrospective and prospective analysis.
Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypothyr | 1990 |
Serum thyroid hormone changes in head and neck cancer patients treated with microwave hyperthermia on lymph node metastasis.
Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Human | 1990 |
Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma.
Topics: Adolescent; Adult; Female; Head and Neck Neoplasms; Hodgkin Disease; Humans; Hypothyroidism; Ion Exc | 1971 |
Managment of functioning thyroid cancer.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Digestive System; Female; Head and Neck Neoplasms; Hospitalizat | 1969 |